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Abstract
Dietary supplements have grown in popularity in recent years, with multivitamins the
most commonly used. As the awareness of dietary supplements continues to increase, there are
more chances for consumers to misuse or misunderstand the risks of taking dietary supplements.
Public relations, physicians, and pharmaceutical companies should work to educate the consumer
about the uses and risks of supplements. This paper addresses the issues associated with dietary
supplements, particularly in the area of weight-loss supplements. Adverse side effects are
addressed, as well as how public relations can influence the outcome of pharmaceutical
companies’ relationships with consumers. Public relations can help the target audiences build
trust with companies, though at times marketing supplements can interfere with a healthy
lifestyle. The lack of regulation on dietary supplements provides consumers with more freedom,
but also leaves room for uncertainty and confusion about the science behind dietary supplements.
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Chapter 1
Introduction
Statement of the Problem
This study means to develop a stronger consumer relationship with pharmaceutical
companies in the area of dietary supplements. The consumer’s understanding of these dietary
supplements should be derived from the effects of marketing and a physician’s expertise in a
healthy and safe manner. The marketing affects the companies’ ability to sell their products, as
well as how consumers interpret the cost and effectiveness of the drug. “Thus, drug marketing—
and even supplement marketing—should be treated with caution lest such products seduce
consumers into treating them as ‘get out of jail free’ cards” (Bolton, Reed, Volpp, and
Armmstrong, 2007, p. 725).
After the enactment of the Dietary Supplement Health and Education Act of 1994
(DSHEA), supplements went from being considered foods to simply dietary supplements
(Nichter, 2006). By improving consumer education of dietary supplements through marketing,
advertising, and physician knowledge, pharmaceutical companies can build a stronger
relationship with users of dietary supplements. This relationship can bring a deeper
understanding of the consumers’ wants and needs.

Background of the Problem
There is not much information about the consumers’ knowledge of regulation on dietary
supplements. Many experiments on supplement knowledge focus on reactions from consumers
and perceptions of dietary supplements from marketing and advertising. The majority of
supplement sales are done directly to the consumer, in pharmacies, health food stores, or
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supermarkets (Temple, 2010). “Nevertheless, whenever a customer asks for advice, the staff is
usually uninhibited in recommending the purchase of one or more supplements” (Temple, 2010).
Marketing techniques should improve upon the knowledge of supplement usage and the science
in producing supplements, rather than on the supplement itself. By providing the background of
how supplements are manufactured, as well as how supplements achieve their cost (making the
information available to the public), companies would be able to communicate better with
consumers.
Under the DSHEA, “products will not require U.S. Food and Drug Administration [FDA]
approval or submission of efficacy and safety data prior to marketing under the new regulation”
(Sadovsky, Collins, Tighe, Brunton, and Safeer, 2008). This act allows consumers to gain
freedom in deciding the supplements he or she can use. With this freedom, comes a risk that the
supplements’ side effects would be overlooked by the consumer. This risk brings
pharmaceutical companies into the domain of those to be at fault if the consumer does not
comprehend the side effects.
With the increased use of dietary supplements in the U.S., the release of knowledge and
education of consumer is much needed. Sadovsky et al. (2008) mentioned in a study that the
dietary supplement use among U.S. adults was 73 percent in 2002. The high percentage should
lead pharmaceutical companies and physicians to obtain a hand in how the marketing of
supplements can affect their consumers through providing, in detail, the abilities and risks of the
supplements and any reactions with prescription drugs.

Purpose of the Study
Improving marketing strategies will provide pharmaceutical companies to present and
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study how consumers of dietary supplements respond to advertising. Many companies increase
the costs of the supplements and drugs, but neglect to include better access to knowledge about
the uses and dangers about the supplements’ handlings. In a study performed on 535 supplement
products (produced by 238 companies), the most common issue seen on noncompliant products
was “having no or [an] incomplete disclaimer with a structural/functional claim” (Meer, Misner,
and Meer, 2004). Sixty-five percent of the products screened were noncompliant when
compared with recent regulations (Meer et al., 2004). This astounding number should drive
companies to take care in the marketing and labeling of dietary supplements.
The majority of dietary supplements do not require a prescription. The freedom
consumers hold can put many parties at risk, if the dietary supplement is misused. For this
reason, marketing the supplements needs care. Developing a relationship with the consumer,
deeper than simply a “box” connection, will draw the consumer into the necessities about
specific knowledge on the supplement. In addition, pharmaceutical companies lose revenue with
the lost relationships. “A $280 billion opportunity is left behind each year due to the failure of
pharmaceutical companies to retain their customers” (LaFountain, 2011). The large amount lost
due to consumer relationships, is the “equivalent to of the combined total global revenue in 2009
for the top six pharmaceutical companies” (LaFountain, 2011). By investigating the amount of
the consumer’s awareness of the regulations on dietary supplements, pharmaceutical companies
and physicians will benefit from marketing strategies compelled to creating a long-lasting
relationship with the consumer.

Setting for the Study
This study will be performed as a piece in the data collection for a Senior Project at
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California Polytechnic State University in San Luis Obispo, California. Three interviews will be
conducted, each an expert in the fields of public relations, pharmacology, and dietary needs
(dietitian). Each expert will be asked the same set of questions. The questionnaire is designed to
specifically answer the research questions and fill any voids in previous studies on dietary
supplements and the marketing strategies and regulation knowledge of consumers.

Research Questions
The following research questions were written in conjunction with needed information
and data in the area of dietary supplement marketing and the consumer-pharmaceutical company
relationships. Each question was developed subsequently with examinations of existing material
on the topic. This was performed in order to accurately and effectively address the issues, as
well as to obtain knowledge from certified individuals in the areas of public relations,
pharmacology, and dietary needs (dietitian) for the study.
1. What is the effect of public relations on how pharmaceutical companies readily gain
long-lasting relationships with consumers?
2. How are current marketing strategies affecting consumers’ lifestyles?
3. Do current marketing strategies effectively communicate the risks and uses of dietary
supplements?
4. What is the level of understanding consumers have on the regulations of dietary
supplements?
5. How do prescription drugs interact with the effects of dietary supplements?
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6. The compound naringin is found in many dietary supplements and is known to interact
negatively with certain prescription drugs. How does the presence of naringin affect the
marketing strategies of releasing new drugs and medicines?

Definition of Terms
To assist the reader, the following terms have been defined to clarify their meanings
within the contexts of the study.
Dietary Supplement: any product (other than tobacco) intended to supplement the diet
that bears or contains one or more of the following dietary ingredients: a vitamin, mineral, amino
acid, herb or botanical; or a dietary substance used ‘…to supplement the diet by increasing the
total dietary intake’; or any concentrate, metabolite, constituent, extract, or combination of any
of these ingredients (Sadovsky et al., 2008)
Drug: any article (excluding a device) intended for use in the diagnosis, care, mitigation,
treatment, or prevention of disease and articles (other than food) intended to affect the structure
or function of the body (Bolton et al., 2007, p. 714)
Dietary Supplement Health and Education Act of 1994 (DSHEA): permits manufacturers
to sell products without providing pre-market evidence of safety or efficacy (no FDA approval)
(Ashar, Miller, Pichard, Levine, and Wright, 2007)
Boomerang Effect: consumers within the problem domain (relatively attracted to the
risky behavior) perceive the remedy as a “get out of jail free” card that takes the risk out of risky
behavior, thereby encouraging it (a remedy message opposite to the position intended) (Bolton et
al., 2007, p. 714)
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Naringin: found in grapefruit, contributing to its bitter taste; exerts a variety of
pharmacological effects such as antioxidant activity, blood lipid lowering, anticancer activity,
and inhibition of selected drug-metabolizing cytochrome P450 enzymes, including CYP3A4 and
CYP1A2, which may result in drug-drug interactions in vivo; ingestion of naringin and related
flavonoids can also affect the intestinal absorption of certain drugs, leading to either an increase
or decrease in circulating drug levels (Meisenheimer, 2009)

Organization of Study
Chapter 1 consisted of the statement and background of the selected topic and problem,
as well as the definition of selected terms. Chapter 2 will consist of the review of current
literature and analyzing its effect towards the research questions posed in Chapter 1. Chapter 3
will be the methodology of the study. Chapter 4 will further analyze the research questions and
discuss the answers in-depth in comparison to the current literature and expert knowledge.
Lastly, Chapter 5 will include a summary of the study and suggestions for professionals in the
fields of public relations, pharmacology, and dietary needs (dietitian).
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Chapter 2
Literature Review
The literature review is designed to portray trends and similarities among the chosen
sources of current material. Each section will represent the trends in categories of the sorted
literature.

The “Boomerang Effect” of Public Relations
Marketing strategies can shape the outcome of a consumer’s daily life. Consumers are
bombarded with various advertisements, daily, that can essentially play a major role in how the
consumer chooses to purchase or gain interest in various products. The impact that marketing
has on the consumer can either prevent or assist in a healthy lifestyle. A healthy lifestyle, “helps
to prevent the onset of major premature debilitating conditions” (Bolton et al., 2007, p. 713).
Drug and supplement marketing should help consumers to achieve this way of living.
Health remedy marketing can take the characteristics of either risk-avoidance or remedy
marketing, according to Bolton et al. Ironically, remedy messages lead consumers to “perceive
the remedy as a ‘get out of jail free’ card that takes the risk out of risky behavior, thereby
encouraging it (i.e., a boomerang effect of the remedy message opposite to the position
intended)” (Bolton et al., 2007, p. 714). The “boomerang effect” would give consumers a
“perceived invulnerability by restoring health credentials, and would thereby disinhibit unhealthy
behaviors” (Chiou, Yang, and Wan, 2011, p. 1085). This boomerang effect can lead consumers
to believe marketing messages that may be misleading.
Policymakers tend to target “a typical, common, average or reasonable consumer” when
shaping regulations (Mason and Scammon, 2011, p. 201). The “ ‘typical consumer’ is viewed in
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the regulatory context as having (1) a normal intelligence enabling them to understand messages
and (2) a willingness or interest in acquiring information” (Mason and Scammon, 2011, p. 203).
Believing that the “typical consumer” will tread information down to non-information seekers, is
a risk policymakers take. If information reaches only part of the intended public who consume
dietary supplements, parties involved (policymakers, public relations advisors, company heads)
will attain the brunt of the consequences. The DSHEA of 1994 did not require marketing and
labeling of dietary supplements to require FDA approval (Mason and Scammon, 2011, p. 202).
This regulation, with the intent to enhance consumer freedom and product availability, has the
potential to sway consumers to lead unhealthy lifestyles.
The voids that the DSHEA of 1994 contains, should be filled using research and further
investigation into what the consumer believes as well as understand about supplement regulation.
Enhancing the public relations aspect in pharmaceutical companies by focusing more on how to
provide consumers with information they do not know and attracting their interest, is a viable
path in achieving a healthy lifestyle. Ame Wadler, chair of the U.S. healthcare practice at
Burson-Marsteller, suggests that pharmaceutical companies enhance their image my taking “a
‘bottom up’ approach to communications, in which real people (read: patients) share their stories
of how prescription drugs saved (or significantly improved) their lives” (PR News, 2004, 60
(30), p. 1). By enhancing the image of pharmaceutical companies and their approach to
consumer wellness, consumers may take an interest in doing further research into the
supplements they are using. “One-on-one patient education can work to mitigate the boomerang
effect” and essentially provide consumers with a reference towards the risks and uses of the
supplements being used. Over-the-counter drug status can allow supplements to be used
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incorrectly but when taken with guidance from a physician or further personal research;
supplements’ risks can be decreased.
Improving the quality of the advertisements on supplements as well as increasing
consumer awareness of the regulations on supplements, can help to improve consumer lifestyles
in a positive direction. With pharmaceutical companies developing a sustainable brand, one that
is agreeable and trusted by consumers, can ensure that funding for companies reaches the area of
consumer knowledge. Marketing performance can be increased “by analyzing difficult-tomeasure concepts such as brand perception, industry buzz, reputation and mindshare” (PR
Newswire, 2002, p. 1). With such changes to the marketing strategies of dietary supplements,
the “boomerang effect” can be avoided and further prevented.

Regulations of Dietary Supplements
The Dietary Supplement Health and Education Act (DSHEA) was passed in 1994, with
the consumers’ fear that access to supplements would be limited. Under the DSHEA,
supplements would be classified as “a subcategory of food and frees them from drug safety and
efficacy standards” (Mason, 1998). Though supplements are in a food subcategory, the Nutrition
Labeling Education Act of 1990 did not apply under the DSHEA (Mason, 1998). For a
supplement to be deemed hazardous, the FDA must “provide evidence that the product is unsafe,
contains a controlled substance, or is absent ingredients listed on the product label after the
product has appeared in retail outlets” (Denham, 2011). Health professionals should be
concerned with the lack of efficacy the DSHEA allows companies to put on their labels.
Consumers may be inclined to substitute supplements for prescription drugs, if misleading
information is placed on supplement containers.
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The DSHEA was passed in response to an eosinophilia-myalgia syndrome (EMS)
outbreak in 1989, where 38 people died and 1500 cases of permanent disability were reported
(Denham, 2011). The cause of the outbreak was an impure batch of l-tryptophan, a dietary
supplement that had the ability to increase the levels of serotonin or melatonin in the brain. Ltryptophan was banned in 1991 (Gower, 1999). The number of people affected by the EMS
outbreak, was a result of contamination during manufacturing as well as how readily available
the supplement was to the U.S. population. With the supplement’s use as being an
antidepressant and aiding in sleep deprivation, overdose on the supplement could have occurred
with the lack of regulation on supplement use.
Tighter regulations can help consumers understand the risks involved with taking dietary
supplements (i.e. with prescription medications). The language used for communication on the
labels should be clearly stated for consumers. A necessity to have marketers of dietary
supplements “with regard to what types of information would constitute adequate substantiation
of claims” as well as “a better understanding of appropriate uses of conventional…supplements”
for consumers (Sanders and Levy, 2011). Marketers are concerned with the target audience and
how that audience will react to the wording on labels of dietary supplements. Though parts of the
intended audience may understand the difference between a health and structure/function claim,
others will blur the line between the two terms. “Structure/function claims relate consumption of
the product to the normal functioning of the human body” (Sanders et al., 2011). Health claims,
on the other hand, “describe a relationship between a whole food, food component, or dietary
supplement ingredient, and reducing risk of a disease or health-related condition” (Sanders et al.,
2011). These claims may be influential on a consumer, if the consumer does not know the
difference between the two terms.
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Dietary supplements may be viewed “to provide dietary approaches to help consumers
cope with health conditions, such as mild irritable bowel syndrome, or reducing the risk of
getting common infectious diseases or traveler’s diarrhea” (Sanders et al., 2011). Supplements
may aid in various health uses, but “claims regarding these uses are generally perceived by the
U.S. regulatory agencies as not acceptable for conventional foods or dietary supplements”
(Sanders et al., 2011). Many companies’ intentions for the product to be viewed by audiences as
a dietary supplement may not come across as such if consumers are not educated about the
scientific details of the product. Consumers need tools to associate the scientific basis of the
supplements with the laws and regulations, as laws have a tendency to be less specific than the
basis. Tools such as “guidance documents published by the FDA and other regulatory agencies
but also standards set by private organizations or industry trade organizations” (Sanders et al.,
2011). These tools help consumers understand the difference between claims and what the true
use of the supplement is.
The freedom of the DSHEA allows companies to advertise without pre-approved phrases
or claims. Regulators have the decision-making power to “decide that they are not responsible
for ‘irresponsible’ consumers or ones who neglect information that would be adequate for more
conscientious consumers” (Eggers and Fischhoff, 2004). This responsibility may not be
sufficient with consumers. “Even when the operational intent of such rulings is clear, the
regulatory philosophy that underlies them often is not” (Eggers et al., 2004). Consumer welfare
needs to be considered in all aspects of the claims process. Regulators should have current
education of dietary supplements, and access to supplement research should be readily available
to consumers.
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Consumer Knowledge of Supplement Regulation
There is not much known about the level of understanding that consumers have of
supplements and their regulation. With the enactment of the DSHEA in 1994, consumers were
empowered “to make their own choices, free from governmental restriction” (Ashar et al., 2007).
The amount of knowledge left for consumers to discover, should be aided by the government’s
involvement in providing the needed information to consumers in an accessible manner.
The high percentage of consumers today in the U.S. that use dietary supplements, 73
percent in 2002, deserves guidance and evidence-based claims of the supplements being used.
According to Ashar et al., supplements (as a result of the DHSEA) lack “standardized
guidelines…and dietary supplements can bear unsupported claims”. Under the DSHEA,
“supplements are ‘regulated’ through post-market surveillance but not ‘pre-approved’” (Ashar et
al., 2007). In a study researching patients’ understanding of supplement regulation, 52 percent
did not know that the supplement was not approved by the FDA (Ashar et al., 2007). At the
same time, 63 percent had no knowledge that the advertisement for the supplement had not been
pre-approved (Ashar et al., 2007). Many characteristics are involved with the results of the
study, including education, weight loss, and race. Consumer protection agencies “must consider
the realities of consumer decision making, namely, how consumers understand a
communication’s contents and apply them to their personal circumstances” (Eggers and
Fischhoff, 2004). A study was conducted in the United States on whether weight loss
supplements were pre-market approved for safety by the FDA; more than half of the 1400 adults
surveyed believed weight loss supplements were regulated for safety (Dodge, Litt, and Kaufman,
2011, p. 231). In addition, a similar study was conducted on the knowledge of physicians about
the regulation of dietary supplements. This study showed that, of the questions asked, only 59
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percent of the answers were correct (Dodge et al., 2011, p. 231). Without increasing physician
awareness in conjunction with equal accessibility for the variety of consumers unaware of the
effects of dietary supplements, may “provide some patients with a false sense of security
regarding safety and efficacy of these products” (Ashar et al., 2008).
Direct-to-consumer (DTC) advertising can have an influential effect on consumers. It
can have the ability to “weaken the physician-patient relationship and adversely affect physician
morale” (Ashar et al., 2008). This relationship provides patients (consumers) with confidence
that supplements’ labels are being correctly advertised. “Patients may not realize that combining
dietary supplements with their prescription medications can result in drug-dietary-supplement
interactions” (Sadovsky et al., 2008). DTC advertising can help pharmaceutical companies to
widen brand demand on many prescription drugs and supplements. By giving companies
freedom in marketing strategies, DTC advertising can “provide firms with incentives to attach
missing information to their brands and to disseminate that information to increase brand
demand” (Calfee, 2002, p. 178). DTC advertising can enhance the consumer’s mind, if
physicians participate in spreading supplement information as well as advertisements able to
adapt and reach a variety of consumers (educated and those without informational resources).
With the adversity among consumers of dietary supplements, there is an immediate need
for a stricter regulation on the post-market surveillance of advertisements. “Sales of all
supplements, especially vitamins, have increased rapidly in the past 15-20 years” (Perez, 2011).
The self-reported adverse effects in 2002 (from the Health and Diet survey), conveyed that “33
percent took a dietary supplement instead of a prescription drug to treat or prevent a health
condition, but only 54 percent discussed the substitution with a physician or other healthcare
professional” (Sadvosky et al., 2008). These statistics, showing a lack of consumer confidence
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in supplement risks and uses, portrays the need for tighter regulations. Consumer education
should be evaluated and advertisements need to assist in consulting a physician or another
reference for supplement uses.

Drug-Supplement Interaction
Consumers view dietary supplements as an addition to a diet, safe and natural. Though
this may be in some cases, dietary supplements have been known to interact negatively with
certain prescription drugs. This interaction “between natural products [supplements] and drugs
can unintentionally reduce or increase the effect of the drug, resulting in therapeutic failure, or
increase toxicity” (Joshi and Medhi, 2008). Drug-supplement interaction can be harmful rather
than helpful if consumers are not aware of the scientific research behind many supplements and
drugs.
Various compounds found in supplements can contribute to affecting “the way of
metabolizing certain drugs by binding with drug ingredients, thus reducing their absorption or
speeding their elimination” (Joshi et al., 2008). Cytochrome P450 (CYP450), an enzyme found
in the small intestine, is readily involved in the metabolizing of 50 percent of prescription
medications (Joshi et al., 2008). Research has shown that CYP450 enzymes can be inhibited by
certain bioflavonoids found in grapefruit juice (GFJ). Unlike many citrus beverages, grapefruit
juice “has been demonstrated to interact with a variety of prescription medication” (De Castro,
Mertens-Talcott, Rubner, Butterweck, and Derendorf, 2006). A bioflavonoid (found in GFJ)
involved in the inhibition of certain CYP450 enzymes is naringin (Meisenheimer, 2009).
Naringin is a compound contributing to the bitter taste in grapefruit juice. It also “exerts a
variety of pharmacological effects such as antioxidant activity, blood lipid lowering, anticancer
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activity” (Meisenheimer, 2009). Particularly, naringin inhibits a form of the enzyme CYP450:
CYP3A4 and CYP1A2. Some weight-loss supplements contain naringin and can have the same
effect with prescription drugs as GFJ. The inhibition that can take place with GFJ-drug and
supplement-drug interaction can greatly affect the risks or levels of the drug in the blood stream
(De Castro et al., 2006). “Most notable are its effects on cyclosporine, some calcium
antagonists, and stains, leading to elevation of the serum concentrations of these drugs from 1.5to 15 fold after oral administration” (De Castro et al., 2006). Supplements containing naringin
include: Beta Slim (NBTY, Inc.) and EndoBurn (BSN). Both supplements are involved in
weight-loss, and feature “naringin” on the label in the list of ingredients.
The encounter of supplements with prescription drugs can be deadly if consumers do not
take care to mention uses of supplements with a physician. Many aspects can affect the amount
of supplement use with any prescription medication, including obesity. In the U.S., over half of
adults take prescription medication, and one in six taking three or more medications (Department
of Health and Human Services, 2011). At the same time, many people use weight loss
supplemental products with the growing awareness of the advantages of weight loss products.
These statistics pose a reminder to consumers, pharmaceutical companies, and physicians to be
aware of adverse effects from drug-supplement interaction. “It would…be prudent for
physicians prescribing the affected drugs and for pharmacists dispensing them, to warn patients
not to take them with grapefruit juice” (Joshi et al., 2008).
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Chapter 3
Methodology
This chapter presents the manner in which the data will be collected, who will be in the
collection, how it will be presented, and the delimitations.

Data Sources
For this study, experts in the fields of public relations, pharmacology, and dietary needs
(dietitian) were interviewed with the same set of questions. These questions were designed to
answer the six research questions mentioned in Chapter 1.

Participants
Debby Nicklas, the executive director at French hospital Medical Center, a prominent
medical center for San Luis Obispo residents, was chosen as the public relations expert. John
Headding, a pharmacist with two stores in Morro Bay and Cambria, and was chosen as the expert
in pharmacology. He has his Ph.D. in pharmacology, and will provide a myopic viewpoint
towards the pharmaceutical industry. Dr. Susan Swadener, a clinical dietitian, specializes in
people with eating disorders and disabilities in developments, was chosen as the expert in dietary
needs.

Interview Design
The following questions were designed to answer the research questions mentioned in
Chapter 1. These were asked of each of the experts and serve as data in this study:
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1. What strategies do public relations officials of pharmaceutical companies use to gain
long-lasting relationships with consumers? What aspects of the public relations area are
dedicated to retaining these relationships?
2. In what ways are current marketing strategies affecting consumers’ lifestyles (positively
or negatively)? How are strategies adapting to consumers’ changing lifestyles?
3. Do marketing strategies effectively communicate the risks and adverse side effects that
dietary supplements can have with prescription medication? If so, in what ways? If not,
in what ways could the strategies be improved, and what are the limitations?
4. How do pharmaceutical companies educate consumers about the risks of taking dietary
supplements? What measurements are taken to ensure consumers have the right
education about regulation on dietary supplements? What improvements can be taken?
5. What dietary supplements are known to interact with certain prescription drugs? How
readily are dietary supplements approved by a professional, or suggested by a
professional?
6. How often are dietary supplements brought to the attention of physicians or a
professionals’ attention?
7. Naringin can be found in many weight-loss supplements and is known to interact
negatively with certain prescription drugs. How does the presence of naringin affect the
marketing strategies of releasing new drugs and supplements?
8. Is it common for dietary supplements, particularly weight-loss supplements, to be
inadequately labeled (i.e. leaving out certain ingredients)?
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Data Collection
The method of data collection were three interviews, each with an expert in a field of study
prominent in this study. The interviews were conducted in November 2011. The experts were
asked to answer a questionnaire, designed to answer the research questions mentioned in Chapter
1.

Data Presentation
The data collected during each interview was documented through written verbatim notes
(during and after the interviews) as well as typed answers through email. The notes and typed
answers through email allowed the clarification of any voids that may occur in the context of the
responses.

Limitations
There are some limitations in this study that occurred during the process of the interviews as
well as in the study itself. Due to time constraints, John Headding, Dr. Susan Swadener, and
Debby Nicklas were unable to meet for a face-to-face interview. The interviews with John
Harding and Debby Nicklas were performed over the phone. This placed certain informalities
and clarity of the responses. Also, Debby Nicklas was unable to answer five of the eight
interview questions due to her qualification and experience dealing with dietary supplements.
The interview with Dr. Susan Swadener was done through an email. The quality of the
responses for this particular interview is verbatim to the expert’s knowledge.
In the study itself, there were limitations to the amount of research available for the specifics
of the study. The pharmaceutical effects of naringin were especially difficult to verify, as studies
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done on the topic were minimal. The inadequate confirmation of products found to contain
naringin could not be verified through the use of the internet, as the FDA does not regulate
supplement use. Verification of the existence of products containing naringin was performed at
The Vitamin Shoppe in San Luis Obispo, CA. The availability of many products found on the
internet believing to contain naringin was nominal.

Delimitations
The study was conducted to investigate the effects of public relations on the marketing
strategies of pharmaceutical companies to dietary supplement consumers. It was delimited to
supplements containing naringin and researching marketing strategies pertaining to the
knowledge and education of consumers on dietary supplement regulation. These delimitations
were placed on the study to keep from placing too wide of a scope on the subject.
Delimitations were placed on the experts chosen for this study. This was done to focus the
audience’s view on the areas with a need for change. The areas of public relations,
pharmacology, and dietary needs, were the pieces found to be lacking in research of knowledge
and education of supplement regulations, as well as improving on consumer knowledge and
education.
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Chapter 4
Data Analysis
Chapter 4 will provide descriptions of the participants in the study and summarize the
experts’ answers to the interview questionnaire. The data will be presented in the form of direct
quotations of paraphrased responses, as the length of the interviews was 30 minutes. These
responses will then be analyzed and compared to the existing literature described in Chapter 2 as
well as to the research questions mentioned in Chapter 1.

Description of Participating Experts in Related Fields
Public Relations
Debby Nicklas was chosen as the expert in public relations. She currently holds the position
of Executive Director at French Hospital Medical Center. The hospital has won multiple awards
for its excellence and quality in various areas of healthcare. With this position, she is in contact
with many organizations as well as community members and is involved in situations where
public relations is a the main goal.

Pharmacology
John Headding is the owner of two pharmaceutical stores, one in Cambria and the other in
Morro bay, CA. His expertise as a pharmacist as well as a Ph.D. in Pharmacology will provide a
deeper view into the pharmaceutical industry and the distribution and handling of many dietary
supplements.

20

Dietary Needs
As an expert in dietary needs, Dr. Susan Swadener was chosen due to her knowledge as a
clinical dietitian. She has an MS and Ph.D. in Nutrition from Cornell University as well as being
the Dietetic Internship Director and Lecturer at California Polytechnic State University. She
specializes in people with eating disorders and disabilities. Her years of experience and
expertise in health, wellness, and fitness allow her to place an understanding on consumer needs.

Dietary Supplement Questionnaire
Each expert was asked the same set of questions based on consumer knowledge of dietary
supplement regulation and the effects of public relations on pharmaceutical companies:
1. What strategies do public relations officials of pharmaceutical companies use to gain
long-lasting relationships with consumers? What aspects of the public relations area are
dedicated to retaining these relationships?

Question # 1 was designed to confirm and expand on the existing literature on the
marketing strategies of pharmaceutical companies. It was meant to clarify the specifics of public
relations in comparison to its relationships with consumers.
•

John Headding: “They create relationships with physicians to get in a position to
prescribe their medication, direct-to-consumer marketing, and advertise to pharmacists
directly” (Appendix A).

•

Susan Swadener: “Commercials on TV, ads in magazines, websites, and free samples
[are examples of marketing strategies]” (Appendix B)
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•

Debby Nicklas: “They must try to generate good public relations [PR] that shows
consumers how their product has helped, through testimonials and personal consumer
experiences” (Appendix C).

2. In what ways are current marketing strategies affecting consumers’ lifestyles (positively
or negatively)? How are strategies adapting to consumers’ changing lifestyles?

Question # 2 was designed to exemplify the effects that the marketing of dietary
supplements is capable of having on consumers. It was meant to show the reader the current
marketing strategies with the knowledge of the experts.
•

John Headding: “In a negative view, patients are getting placed on drugs they don’t
need—seeking these drugs from doctors. Positively, more people are aware and educated
about the states of diseases” (Appendix A).

•

Susan Swadener: “Perhaps they are more educated but also they may not need
supplements at all. People today are too busy to eat right, [and strategies play on that
aspect]” (Appendix B).

•

Debby Nicklas: “I think pharmaceutical companies push how their products can
contribute to a happier lifestyle. Baby boomers are a target audience, and the marketing
is more geared towards the positive side of life” (Appendix C).

3. Do marketing strategies effectively communicate the risks and adverse side effects that
dietary supplements can have with prescription medication? If so, in what ways? If not,
in what ways could the strategies be improved, and what are the limitations?
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Question # 3 is meant to show the reader the effectiveness of marketing supplement risks
and uses to consumers. This question poses the thought that current strategies may not be
effective and improvements are needed.
•

John Headding: “Yes and No. Strategies are very detailed in informing the public of
adverse side effect. For those who rely on going to health food stores without seeing a
physician or pharmacist first, there are the harms and dangers of asking advice from
someone who isn’t qualified to answer questions of supplement and drug interactions”
(Appendix A).

•

Susan Swadener: “Not that I am aware of. Strategies should mention medications that
contraindicate [counteract] with the supplement the consumer is taking” (Appendix B).

•

Debby Nicklas: “I think they do [for prescription medications]; they will say potential
side effects. As a consumer, I don’t know about the marketing that dietary supplements
have, whether it’s good or bad” (Appendix C).

4. How do pharmaceutical companies educate consumers about the risks of taking dietary
supplements? What measurements are taken to ensure consumers have the right
education about regulation on dietary supplements? What improvements can be taken?

Questions # 4 is meant to further portray improvements pharmaceutical companies could
be making. This question takes into depth how consumers can be educated on dietary
supplement regulation and the areas that consumers need extensive education of.
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•

John Headding: “They haven’t done a good job. I think there’s a limited amount of
education consumers are exposed to. People are seeking quick fixes and can end up
abusing and misusing products” (Appendix A).

•

Susan Swadener: “I am not aware that pharmaceutical companies are educating
consumers. The measurements being taken include talking to registered dietitians and
looking on the FDA website” (Appendix B)

•

Debby Nicklas: N/A (Appendix C).

5. What dietary supplements are known to interact with certain prescription drugs? How
readily are dietary supplements approved by a professional, or suggested by a
professional?

Question # 5 is meant to show the reader the supplements that interact with prescription
drugs so the reader is aware of what he or she is taking. The question is also designed to clarify
the availability of supplements and how professionals can be involved in the process of choosing
a supplement.
•

John Headding: “Literally every product that’s over-the-counter has an interaction with a
prescription medication. Supplements are commonly suggested by professionals, but
over-the-counter marketing can be potentially harmful, especially at health food stores”
(Appendix A).

•

Susan Swadener: “Tryptophan and St. Johns Wort with SSRIs are known to interact with
proscription drugs. Supplements are readily suggested if proven effective for that
particular patient” (Appendix B).
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Debby Nicklas: N/A (Appendix C).

•

6. How often are dietary supplements brought to the attention of physicians or a
professionals’ attention?

Question # 6 was designed to bring attention to the consistency of supplement usage that
physicians and professionals are aware of. It is meant to encourage consumers to seek out
professional advice if they are taking prescription medications and dietary supplements.
•

John Headding: “Rarely ever are dietary supplements brought to our attention. There is
mainly direct-to-consumer advertising; there isn’t much advertising towards
physicians” (Appendix A)

•

Susan Swadener: “I always ask my clients as a registered dietitian” (Appendix B)

•

Debby Nicklas: N/A (Appendix C).

7. Naringin can be found in many weight-loss supplements and is known to interact
negatively with certain prescription drugs. How does the presence of naringin affect the
marketing strategies of releasing new drugs and supplements?

Question # 7 is meant to focus more particularly on products containing naringin, a
delimitation placed on this study. Naringin’s presence in many weight-loss supplements is
important when many Americans have tried or use these supplements.
•

John Headding: “Through the FDA, the more problems with a supplement, the FDA will
step in and either pulls it from the shelves or put restrictions on it. If naringin has
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problems, then marketing strategies are either halted or altered depending on what
problems the FDA is aware of” (Appendix A).
•

Susan Swadener: “Marketing strategies need to tell consumers that it can decrease the
metabolism of certain drugs and therefore causing toxic levels” (Appendix B).

•

Debby Nicklas: N/A (Appendix C).

8. Is it common for dietary supplements, particularly weight-loss supplements, to be
inadequately labeled (i.e. leaving out certain ingredients)?

Question # 8 was put in to show any inadequacies that labeling dietary supplements has.
This is important and consumers need to know what they’re taking and how the supplement can
affect his or hers lifestyle.
•

John Headding: N/A (Appendix A).

•

Susan Swadener: “Sure, many times the supplements contain too little or too high
amounts of the active ingredient” (Appendix B).

•

Debby Nicklas: N/A (Appendix C).

Dietary Supplement Research Questions
For this study, the following six research questions were created to determine to current
marketing strategies used by pharmaceutical companies towards dietary supplement consumers,
consumer knowledge of the regulation of dietary supplements, and the supplement-drug
interaction in the human body.
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Research question 1: What is the effect of public relations on how pharmaceutical
companies readily gain long-lasting relationships with consumers?

•

“Building a sustainable brand is critical in the pharmaceutical industry because of the
enormous investment in research and development” (PR News, 2002).

•

“Producers often communicate with consumers through labels and other forms of
advertising. If the content is accurate and understood, such communications can help
consumers make choices in their own best interest…agencies must consider the realities
of consumer decision making, namely, how consumers understand a communication’s
contents and apply them to their personal circumstances” (Eggers et al., 2004).

Research question 2: How are current marketing strategies affecting consumers’ lifestyles?

•

Bolton et al. states that remedy messages lead consumers to “perceive the remedy as a
‘get out of jail free’ card that takes the risk out of risky behavior, thereby encouraging it
(i.e. a boomerang effect of the remedy message opposite to the position intended)”
(p.714).

•

“In the regulatory world, the strategy of targeting information-sensitive consumers is
commonly accepted among policymakers and scholars due to the positive externalities
that should indirectly benefit non-information-seeking consumers. The informationsensitive segment is presumed to play a market-perfecting role in stimulating positive
seller responses upon which other segments may free ride” (Mason et al., 2011).

27

Research question 3: Do current marketing strategies effectively communicate the risks
and uses of dietary supplements?

•

“The probiotic community…expressed a need to better understand U.S. regulatory
agency expectations of marketers of probiotic products with regard to what types of
information would constitute adequate substantiation of claims on probiotic products”
(Sanders et al., 2011).

•

“The concern is that consumers may not differentiate between technical descriptions and
marketing language and may attempt to use dietary supplements in place of medicines
that have been tested in rigorous trials” (Denham, 2011).

•

“Until a more systematic wide-reaching strategy is adopted, physicians need to assume an
active role in educating their patients about the lack of governmental involvement in both
the premarket evaluation of supplements and the pre-approval of their advertisements.
These efforts would assist patients in making well-informed choices rather than ones
based on marketing propaganda” (Ashar et al., 2007).

Research question 4: What is the level of understanding consumers have on the regulations
of dietary supplements?

•

“In bivariate analysis, a lower level of education, non-Caucasian race, perception of
being underweight or of normal weight, and having never tried to lose weight were all
associated with being inadequately informed that the FDA does not approve dietary
supplements” (Ashar et al., 2007).
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•

“One brand of Echinacea is labeled this way: ‘Echinacea is the world’s best known herb
for nutritionally supporting defense system functions.’ Elsewhere on the package, it says
that the product ‘maintains healthy immune functions.’ Consumers effortlessly interpret
these statements to mean that the product will help them fight off a nasty virus” (Nichter
et al., 2006, p.177).

•

“…individuals do not understand the broader implications of the DSHEA. As a result,
when consumers make decisions about whether to use a dietary supplement, they may do
so with inaccurate or incomplete information” (Dodge et al., 2011, p. 236-237).

Research question 5: How do prescription drugs interact with the effects of dietary
supplements?

•

“Natural products can ‘interact’ with drugs by affecting the biological processes that
regulate their metabolism and elimination. Cytochrome P450 is the system of enzymes
that are abundantly involved in the metabolism of many drugs” (Joshi et al., 2008).

•

“The intestinal CYP450 3A4 appears to be subjected to a mechanism-based inactivation
by compounds present in grapefruit juice [GFJ]” (De Castro et al., 2006).

•

“Basically the nature of herb-drug interaction is not a chemical interaction between the
drug and the herb component to produce a toxic effect. Instead, the interaction may
involve an herb component causing either an increase or decrease in the amount of drug
in the blood stream” (Joshi et al., 2008).
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Research question 6: The compound naringin is found in many dietary supplements and is
known to interact negatively with certain prescription drugs. How does the presence of
naringin affect the marketing strategies of releasing new drugs and medicines?

•

“Among GFJ components, the flavonoids naringin, naringenin,…have been suggested to
contribute to GFJ-drug interaction” (De Castro, 2006).

•

“Co-administration of grapefruit juice and/or purified bioactive compounds may inhibit
CYP 3A4 and transporter proteins partially or fully. This type of strategy may reduce the
dose of drugs and lead to a reduction in the cost of expensive medications by means of
decreasing the first-pass metabolism” (Girennavar, Jayaprakasha, Jifon, and Patil, 2007,
p.1274).

•

“Manufacturers need to be more aware of the risk to the company, as well as to the
public, of failing to provide adequate warning and they need to put in place mechanisms
for earlier awareness of such risks and for ways to deal with them” (Joshi et al., 2008).

Dietary Supplement Data
For this study, three experts were asked identical questions to gain more in-depth
knowledge about the effects that dietary supplements can have in conjunction with prescription
medication as well as the effects of public relations on the marketing strategies of pharmaceutical
companies. John Headding, Dr. Susan Swadener, and Debby Nicklas were interviewed for their
expertise in the areas of pharmacology, dietary needs, and public relations, respectively. The
following tables demonstrate the respondents’ answers in relation to the six original research
questions.
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Research question 1: What is the effect of public relations on how pharmaceutical
companies readily gain long-lasting relationships with consumers?
This question was designed to gain insight to the public relations tactics being used
today. These tactics represent how relationships with consumers have developed or wilted as a
result of the execution of the tactics. From the literature, a sustainable brand and accurate
labeling on the products will gain consumer trust which leads to the formation of a relationship.
Table 1 shows similar answers between the three experts: public relations is a key to the
progression of a long-lasting relationship.

Table 1
The Effect of Public Relations
Respondent

Relationships are created
through…

Tactics

John Headding

Educated pharmacists and
physicians

Direct-to-consumer marketing

Susan Swadener

Strategic marketing

Commercials, ads, websites,
and free samples

Debby Nicklas

Good public relations

Testimonials and personal
consumer experiences

Research question 2: How are current marketing strategies affecting consumers’ lifestyles?
Marketing and advertising can affect the consumer’s lifestyle. At the same time, the way
consumers go about day-to-day business affects how marketing strategies are created. This
question is meant to expand on how current marketing strategies are affecting the way consumers
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live, either positively or negatively. From the literature, a “boomerang effect” occurs when
consumers take a remedy message as a ‘get out of jail free card’, and similar effects were found
in many studies. This question will lead the reader into finding gaps in current strategies and
realizing there is need for change.
In Table 2, there were slight differences between the three experts. On the positive side,
the experts’ responses were similar. Negatively, Susan Swadener and John heading agreed.
These differences can be attributed to each expert’s field of study. The three responses covered
parts of the question that were not directly discussed.

Table 2
Effects of Current Marketing on Consumers’ Lifestyles
Respondent

Positive Effect

Negative Effect

John Headding

Increased disease awareness
and education

Short consultations with
physicians lead to unneeded
use of drugs

Susan Swadener

Increased consumer education

Consumer may not need the
supplement at all

Debby Nicklas

Marketing is more geared
towards creating a positive
way of life

Strategies are more adapting
to an older population

Research question 3: Do current marketing strategies effectively communicate the risks
and uses of dietary supplements?
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This question is meant to dig deeper into how current marketing strategies are providing
consumers with the needed information about dietary supplements and the risks of taking
supplements with prescription medication. The literature suggested that tighter regulation by a
governmental agency was needed. This regulation would put pharmaceutical companies in a
position to release information (labeling) that was accurate and backed by scientific evidence. If
tighter regulation is out of reach, physicians and other educated professionals should actively
educate consumers (providing a place to seek advice).
Table 3 presents the experts responses as being similar. There was uncertainty with how
marketing strategies have effectively communicated to consumers. John Headding’s response
states that educated physicians and pharmacists should handle questions regarding dietary
supplements. Health food store associates may not be as qualified as physicians to handle a
patient’s supplement and drug intake.

Table 3
Risk and Use Communication of Dietary Supplements
Respondent

Effectiveness

Improvements

John Headding

Both good and bad; more
people recognize risks, but
public may be seeking advice
from uneducated sources

Tighter regulations on
supplement marketing and
improve physician-consumer
relationship

Susan Swadener

Not aware of marketing’s
effectiveness

Mention medications that
produce adverse side effects
when taken with supplements

Debby Nicklas

Not sure, as a consumer,
whether it’s good or bad

Not sure, as a consumer
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Research question 4: What is the level of understanding consumers have on the regulations
of dietary supplements?
By understanding consumer knowledge, pharmaceutical companies can better gauge the
measures that must be taken to improve on educating consumers (in areas that have gaps). This
question provides the basis to which the reader can trace to changes that should be taken. From
the literature, consumers are not aware that there are no regulations on supplements. Certain
factors contribute to consumer awareness, education, race, and those who have never tried to lose
weight (or gain interest in taking supplements). These factors result in risks pharmaceutical
companies take when availability of the background of supplements is presented in a manner that
consumers do not understand. The language on the labeling may be unfamiliar to the consumer,
and he or she may not research the product any further than what’s shown on advertisements or
on the label.
The contents of Table 4 confirm that there are few measures being taken to educate the
consumer. John Headding and Susan Swadener have similar answers, while Debby Nicklas was
not able to respond to the question. The level of understanding pertains to the general public, not
the experts themselves. The table allows the reader to clarify the research with expert opinions.
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Table 4
Knowledge of Dietary Supplement Regulation
Respondent

Consumer Level of
Understanding

Improvements

John Headding

Moderate

Increase measurements on
consumers education

Susan Swadener

Minimal

Increase communication with
registered dietitians and place
regulations on the label

Debby Nicklas

N/A

N/A

Research question 5: How do prescription drugs interact with the effects of dietary
supplements?
The scientific background to the drug-supplement interaction is important to creating
marketing strategies that promote a safe and healthy consumer lifestyle. Many prescription
drugs interact with dietary supplements, and consumers should be aware of any interaction if he
or she is taking medication along with supplements. The current literature describes drugsupplement interaction by increasing the amount of the medication in the blood stream. This
increase into the blood stream can create adverse side effects from the drug. Drug-supplement
interaction should have precautions and availability of research for the consumer. Table 5
provides confirmation of the current literature.
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Table 5
Supplement Interaction with Medication
Respondent

Level of Interaction
with Drugs

Physician Awareness

Example of Drug

John Headding

Every product that’s
over-the-counter has
an interaction with a
medication (there’s a
range of interaction)

Supplements are
commonly suggested

Not sure

Susan Swadener

Common, many
interact with at least
one medication

Supplements are
readily suggested, if
proven effective; asks
clients if he or she is
taking a supplement

Tryptophan and St.
John’s Wort

Debby Nicklas

N/A

N/A

N/A

Research question 6: The compound naringin is found in many dietary supplements and is
known to interact negatively with certain prescription drugs. How does the presence of
naringin affect the marketing strategies of releasing new drugs and medicines?
This question was designed to focus the reader’s attention on the delimitation of naringin
and specifically, weight-loss supplements. By focusing on supplements containing naringin and
consumers using or have taken weight loss supplements, it narrows the audience and area of
study. By presenting how naringin interacts with certain prescription drugs, similar drugsupplement interactions can be handled in a similar manner (through marketing strategies and
public relations).
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From the literature, the flavonoid naringin has been found to contribute to the inhibition
of a drug-metabolizing cytochrome P450 3A4. This inhibition has a major effect on how certain
drugs can be taken, especially if naringin is a compound found in the supplement the consumer is
taking. Table 6 presents expert responses of how marketing strategies adapt to drug-supplement
interaction. The answers were similar and Susan Swadener suggested an improvement to current
strategies.

Table 6
Effects of Naringin
Respondent

Effects of Naringin

Quality of Labeling

John Headding

The FDA has the ability to
pull a product if there are too
many problems

N/A

Susan Swadener

Consumers should know that
naringin can decrease the
metabolism of certain drugs
which can lead to toxic levels
in the blood stream

Can be inadequate;
supplements may contain too
little or too high amounts of
the active ingredient

Debby Nicklas

N/A

N/A
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Chapter 5
Discussion and Recommendations
Summary
This study was performed to gain additional knowledge about the complexities of
marketing strategies and public relations in the pharmaceutical industry. With personal
experience working with the compound naringin, it was with a fascination to narrow the focus of
the study to the effects of naringin on prescription medication. The scientific background of
dietary supplements is essential to successfully developing a marketing strategy or public
relations plan. The level of knowledge that consumers have of the science behind supplements,
was shown to be minimal.
With many studies portraying the low level of consumer knowledge about regulations on
supplements and drug-supplement interaction should concern many physicians, pharmacists,
dietitians, and pharmaceutical companies. The well-being of the consumer rests in the
consumer’s own ability to delve into research regarding a supplement he or she has been taking
or is interested in taking. Though some consumers will research the science, many are unable to
access such information. Here, health professionals should step in and assume the active role in
educating consumers.
To find more information on current marketing strategies and general knowledge about
dietary supplements, an expert from each field (pharmacology, dietary needs, and public
relations) was interviewed with a questionnaire designed to answer the six original research
questions for the study:
1. What is the effect of public relations on how pharmaceutical companies readily gain
long-lasting relationships with consumers?
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2. How are current marketing strategies affecting consumers’ lifestyles?
3. Do current marketing strategies effectively communicate the risks and uses of dietary
supplements?
4. What is the level of understanding consumers have on the regulations of dietary
supplements?
5. How do prescription drugs interact with the effects of dietary supplements?
6. The compound naringin is found in many dietary supplements and is known to
interact negatively with certain prescription drugs. How does the presence of
naringin affect the marketing strategies of releasing new drugs and medicines?

The six research questions were modified for the questionnaire. The altered questions
were designed to allow each respondent to relate to the content of the study, while still retaining
knowledge from the expert’s field of study. The responses from the questionnaire were tied into
the current literature on the effects of public relations on the marketing of dietary supplements.

Discussion
With the collected data from Chapter 4, conclusions were drawn and tied into the current
literature discussed in Chapter 2. These conclusions are shown in relation to the six original
research questions.

Research question 1: What is the effect of public relations on how pharmaceutical
companies readily gain long-lasting relationships with consumers?
All three experts had similar positive responses. Dr. Susan Swadener gave examples
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of tactics including free samples, commercials, and advertisements. John Headding found both a
positive and negative side to marketing strategies. Debby Nicklas found that testimonials were a
good public relations tactic. These responses show that public relations tactics cover a variety of
areas. The three experts differed in how long-lasting relationships were created: good public
relations, educated physicians and pharmacists, and strategic marketing.
The literature reflected a similar standpoint. Accuracy of marketing affects “how
consumers understand a communication’s contents and apply them to their personal
circumstances” (Eggers et al., 2004). This accuracy alongside consumers seeking advice from
educated health professionals, will allow a long-lasting relationship to grow. John Headding
described how pharmaceutical companies can place a product on a news venue, and as a result
consumers will ask physicians about the advertised product. This is a form of direct-toconsumer advertising.
Overall, long-lasting relationships with consumers exist if there is accuracy in marketing
and tactics are being used. Educated health professionals play an important role in the way
consumers are affected by supplement marketing strategies.

Research question 2: How are current marketing strategies affecting consumers’ lifestyles?
Generally, the three experts viewed current marketing strategies as increasing consumer
awareness. According to John Headding, “more people are aware of disease states and becoming
educated, and more people are getting vaccinated”. The experts also agreed that marketing
strategies were adapting to consumers’ changing lifestyles. By appealing to the consumer’s need
to stay young and with no time to eat right, pharmaceutical companies are modifying public
relations to be more relatable to the consumer.
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The literature suggests that negative effects of drug and supplement marketing are
happening frequently. Bolton et al. pointed out that “there is less opportunity for one-on-one
patient education with over-the-counter versus prescription drugs” (2007, p. 718). This point
poses a threat for consumers creating a healthy lifestyle from the current marketing strategies.
“Misleading advertising can lead to improper public consumption of potentially toxic
supplements” (Ashar et al., 2007). The literature finds that supplement marketing can be
harmful or helpful depending on the audience involved.
Overall, the literature and experts disagreed and agreed in areas. Both agreed that
marketing strategies were adapting to consumer lifestyles, but the experts found that there could
be both a positive and negative effect on consumers. From the literature and experts, it proposes
that supplement marketing can only be effective if the correct audience is targeted and the
audience is educated enough to understand and respond cautiously to the marketing.

Research question 3: Do current marketing strategies effectively communicate the risks
and uses of dietary supplements?
Dr. Susan Swadener and Debby Nicklas were uncertain about whether the risks and uses
were effectively being communicated through supplement marketing. John Headding put a
positive and negative side to the strategies. As the negative, he asserts that “health food stores
aren’t qualified to address a patient’s health; it is detrimental for consumers”. Health
professionals should be the only source of advice after consumers view a supplement
advertisement.
The literature places an active role on physicians and health professionals to compensate
for the technical language that many advertisements can contain about supplements. Consumers
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should have “a better understanding of appropriate uses of conventional foods or supplements for
targets affected by probiotics” (Sanders et al., 2011, p. E2). The regulations of supplements were
not observed in the amount of education consumers had. Increased consumer education about
the risks and uses of supplements is needed.
Overall, there were similarities about and increase in FDA regulation on the language
used on labels as well as greater consumer awareness about the regulations that supplements
have.

Research question 4: What is the level of understanding consumers have on the regulations
of dietary supplements?
Debby Nicklas was not applicable to answer this question. Dr. Susan Swadener was
unsure and unaware that pharmaceutical companies were educating consumers as well as
consumers’ level of understating of supplement regulations. According to John Headding,
pharmaceutical companies “haven’t done a good job, there’s a limited amount of information
made available for consumers”. Consumers’ understanding of supplement regulations is
minimal.
A low level of consumer understanding of supplement regulations was observed in the
literature as well. Factors that contributed to this low level include: “a lower level of education,
non-Caucasian race, perception of being underweight or of normal weight, and having never
tried to lose weight” (Ashar et al., 2007, p. 25). Dr. Susan Swadener suggested that the
regulations should be placed on the label of each supplement product.
Overall, the experts’ opinions and the literature provided similar answers. Consumer
knowledge of supplement regulation is marginal, and there should be an increase in FDA
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involvement in educating consumers. The uncertainty of Dr. Susan Swadener and Debby
Nicklas shows that experts, as consumers, are unaware of measures being taken to inform
consumers of supplement regulations as well as the level of consumer understanding on the
topic.

Research question 5: How do prescription drugs interact with the effects of dietary
supplements?
Debby Nicklas was not applicable to answer this question. John Headding stated that
“literally every product that’s over-the-counter has an interaction with some drug”. Dr. Susan
Swadener gave two examples of supplements that interact with drugs: St. John’s Wort and
Tryptophan.
The literature described the scientific background of how supplements interact with
prescription medication, and how consumers can be at risk if there is no awareness of the
interaction. “The interaction may involve an herb component causing either an increase or
decrease in the amount of drug in the blood stream” (Joshi et al., 2008). This interaction can
produce adverse side effects if the consumer is not educated about drug-supplement interactions.
Overall, the literature provided the scientific background to the drug-supplement
interaction, while the experts brought information regarding how great of an effect drugsupplement interaction can have on health professional awareness. Without physician or a health
professional’s awareness, some consumers can be unaware of the adverse effects that
supplements can have with drugs.
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Research question 6: The compound naringin is found in many dietary supplements and is
known to interact negatively with certain prescription drugs. How does the presence of
naringin affect the marketing strategies of releasing new drugs and medicines?
Debby Nicklas was not applicable to answer this question. If naringin can produce
adverse side effects through its interaction with a supplement, in a large number of people, “the
FDA steps in and has the ability to pull it from the shelf or ban it completely”, according to John
Headding. The effects of naringin should be made available to consumers with newly released
drugs have the ability to interact with a supplement containing naringin.
Consumer awareness of drug-supplement interactions raises concerns when many people
are not educated enough to understand its scientific background. “Actually, herbal medicines
either mimic, or increase, or decrease the action of prescribed drugs. This can be especially
important for drugs with narrow therapeutic windows and in sensitive patient populations such as
older adults, the chronically ill, and those with comprised immune systems” (Joshi et al., 2008).
The literature showed that the scientific background of drug-supplement interaction is essential
to creating successful marketing strategies.
Overall, both the literature and the experts were concerned about consumer awareness of
drug-supplement interactions. The literature took a deeper look into how the interaction occurs
in the human body, and the experts provided insight into the level of professional awareness of
drug-supplement interactions.

Recommendations for Practice
After completion of the study, the expert knowledge and literature research was analyzed
and compared on the topic of public relations and its effects on marketing towards dietary
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supplement consumers. Given the information from the collected research, it is imperative that
the main points of the study are addressed to inform future public relations, pharmacology,
pharmaceutical companies, and dietary needs professionals. Recommendations for practice
include increasing consumer awareness about the regulations, risks, and uses of dietary
supplements; making essential information about drug-supplement interactions available to
health professionals and consumers; lobbying for tighter FDA regulations of the language written
on supplement labels; and pushing pharmaceutical companies towards self-regulation of released
advertisements (ensuring accuracy and legitimacy).
Increase Consumer Awareness.
Consumers are essential to a pharmaceutical company’s revenue and popularity among
communities. A consumer’s trust in a brand can affect the longevity of the relationship with the
pharmaceutical company. To increase consumer awareness, and in turn the consumer’s trust,
companies should use tools such as Internet websites (to display clear and concise information
on dietary supplement use, risks, and regulations) and make pamphlets available at medical
centers displaying essential supplement information (contacts and websites to visit). Health
professionals can also increase awareness by addressing issues in physician-patient
consultations.
The results of consumer relationships can be influential on pharmaceutical companies
and health professionals. “Information disclosure has become the preferred consumer protection
remedy advocated by economists, the courts, regulators, and business” (Mason et al., 2011). By
actively providing consumers with tools to educate themselves on the risks, uses, and regulations
of dietary supplements, companies are more likely to achieve a long-lasting relationship with the
consumer.
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Increase Health Professional Awareness.
Health professionals include pharmacists, dietitians, and physicians. These areas of
expertise provide a safe haven for consumers when he or she becomes uncertain about a
condition, drug, or supplement. Debby Nicklas was unable to answer five of the eight interview
questions, due to her qualification and awareness of dietary supplement knowledge. This adds to
the urgency that falls on producing greater health professional awareness. Increasing health
professional awareness about drug-supplement interactions makes these professions more
educated and able to answer questions consumers can bring into conversation. Similar tools can
be used to increase professional awareness that can be used to increase consumer awareness:
pamphlets in medical centers and Internet websites (to display clear and concise information on
drug-supplement interaction. Health professional conferences about dietary supplements can
also help to generate awareness.
John Headding provided insight to pharmacist awareness on supplements, and explained
that many health professionals must do outside research into dietary supplement information
(relatable to the patient). The information is not readily provided to professionals in textbooks.
Generating professional awareness by using a variety of tools will allow for consumers to seek
advice from better educated sources. This can in turn affect the public relations of
pharmaceutical companies and how marketing strategies are created to reach to consumers.
Tighter Regulations on Labels.
The label of dietary supplements has the ability to hold many important points about the
ingredients, uses, and risks. As many supplement consumers come from a variety of
backgrounds, companies cannot be sure that each consumer reads the label the same way. The
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technical language of the science behind supplements can be misread by consumers with no
medical background.
The claims that exist on labels may have been done through an advertising process or
with the basis of proven research. In a study conducted on the compliance of supplement
labeling with regulatory standards, 65 percent of noncompliant products had the main issue of
“having no or incomplete disclaimer with a structural/functional claim” (Meer et al., 2004). This
large percent and with the increasing amount of consumers using supplements, it is crucial that
tighter regulations on supplement labeling exist. This will ensure that consumers without a
medical background can correctly and safely use a product without misreading the label
information.
Pushing Self-Regulation.
Marketing strategies for pharmaceutical companies can at times get carried away with
increasing revenue, without thinking about consumer wellness. The little regulation that
supplements have, leaves room for improvisation and also inaccuracy. Self-regulation is a step
in the direction of enhancing consumer safety and being able to be associated with responsibility.
Formally, there are no measurements that the government takes on a supplement prior to
market release. Dr. Susan Swadener suggested that consumers “talk to registered dietitians and
look on the FDA website” for answers to questions. These methods can be effective, but can
also be harmful to consumers if he or she has no knowledge of what to look for. Pharmaceutical
companies should take the necessary actions to self-regulate each other in the area of dietary
supplements. This assertion will bode well with consumer trust and creating long-lasting
consumer relationships.
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Study Conclusion
The general findings from this study have shown that further investigation needs to be
performed with regards to the amount of knowledge consumers have on dietary supplements.
This knowledge will aid public relations and marketing officials in successful strategies to
develop trust and long-term relationships with consumers. Customary data should be collected
to learn what knowledge consumers have on dietary supplements as well as the effectiveness that
marketing strategies and public relations have on the awareness of supplement uses and risks.
With the variety of backgrounds, it is difficult to reach out to each consumer by means of
dispatching necessary supplement information. As a result, this study is meant to provide
attention to the problems and solutions that are and can be associated with the marketing and
public relations of dietary supplements. It also serves as an educational guide for many
consumers who seek additional knowledge about the science and risks that are associated with
dietary supplements. Ultimately, anyone interested in the topic and background of dietary
supplements may use it as an in-depth look into the effects that supplements can have on
marketing and public relations.
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Appendix A
Interview Transcripts: John Headding
The following interview was conducted to gain expert opinion in the field of
pharmacology based on a questionnaire about the effects of public relations on pharmaceutical
companies.
Interviewer: Nicole Schmidt
Respondent: Pharmaceutical Store Owner (John Headding)
Date of Interview: 11/30/2011
Interview Transcription:
Nicole Schmidt: “What strategies do public relations officials of pharmaceutical companies use
to gain long-lasting relationships with consumers? What aspects of the public relations area are
dedicated to retaining these relationships?”
John Headding: “I think that there are three different types of strategies that companies use, one,
create relationships with physicians to get into a position where their medications can be
prescribed by those physicians, which can create a direct-to-consumer marketing strategy. Two,
direct-to-consumer marketing involves going on news venues, and in turn the public can be
educated on certain diseases (news stories). This is a very common tool to use now. People will
ask for a certain prescription medication based on what they’ve seen on TV or in ads. Three,
marketing to the pharmacists directly enables them to be educated about medications in more
detail. Companies who provide certain medication will often give discount cards to patients
because of the high prices of medications in this economy. An example would be Liptor; you
can go online and get a coupon so you’re co-pay is lower.
For the second part, once you get a patent on a medication, the relationship to
communicate with the consumer is given to physicians and the education they’ve received.”
NS: “In what ways are current marketing strategies affecting consumers’ lifestyles (positively or
negatively)? How are strategies adapting to consumers’ changing lifestyles?”
JH: “There’s a positive and negative to current marketing strategies. The negative is that patients
are getting placed on drugs they don’t need. People are seeking drugs from doctors based on ads
they’ve seen. Doctors will often acquiesce with patients because of the limited time that is spent
with the patient during the monthly or quarterly visit. The positive side involves the fact that
more people are aware of disease states and are becoming more educated. More people are
getting vaccinated because they are more aware of diseases. An example of that would be
Shingles. Utilization of the product has also increased significantly because people are more
aware and educated.
There’s also a positive and negative side to the second question. The positive is that you
are seeing patients actually improving their overall health, which leads to a more active lifestyle
because diseases are being addressed. This is a major part of current marketing strategies. The
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negative is that you are also seeing patients being harmed because they take medications they
don’t necessarily need.”
NS: “Do marketing strategies effectively communicate the risks and adverse side effects that
dietary supplements can have with prescription medication? If so, in what ways? If not, in what
ways could the strategies be improved, and what are the limitations?”
JH: “Through a professional source, absolutely. They are very detailed in informing the public
of the adverse side effects. Supplements can have questionable marketing. There is
overutilization of over-the-counter health products. But, more people are asking more questions;
they recognize the faults in supplement marketing. Through a source that has not gone through
medical school and put the time into understanding medications and their interaction with the
human body, absolutely not. There are harms and dangers of seeking advice from an uneducated
source. It is not effective communication for supplements to be sold without the proper source
available for consumers. In general, the public is misinformed. Health food stores aren’t
qualified, which can be detrimental to the public. It should be left to physicians and pharmacists,
people who are educated.
NS: “How do pharmaceutical companies educate consumers about the risks of taking dietary
supplements? What measurements are taken to ensure consumers have the right education about
regulation on dietary supplements? What improvements can be taken?”
JH: “They haven’t done a good job. I think there’s a limited amount of information available to
consumers about dietary supplements. People are seeking quick fixes in their lives, and
supplements can be marketed to appeal to having easy solutions. As a result, people are abusing
and misusing products. Currently, there are no measurements being taken to evaluate the amount
of education available to consumers. Formally there’s nothing, but individual measurements can
be taken when people see a physician or pharmacist.
NS: “What dietary supplements are known to interact with certain prescription drugs? How
readily are dietary supplements approved by a professional, or suggested by a professional?”
JH: “Literally every product that’s over-the-counter has an interaction; there isn’t one that
doesn’t interact. But, there’s a range in terms of the interaction. It takes just a qualified
conversation with a patient to see if a consumer is taking a dietary supplement that may be
harmful to his or hers health. Supplements are commonly suggested to patients. For those
professionals that are educated, the concern with health food stores [HFS], especially with overthe-counter marketing, is that people will seek advice from HFS which can be potentially
harmful to a patient’s health. There is no opportunity to interact with someone to evaluate if they
are taking prescription medication or what their health conditions are.”
NS: “How often are dietary supplements brought to the attention of physicians or a
professionals’ attention?”
JH: “Rarely ever. Physicians usually have to ask if a patient is taking a supplement. Over-thecounter product information is not often available to physicians through textbooks. Physicians
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have to seek out the information themselves through outside sources, and there can be good and
bad information on the internet.”
NS: “Naringin can be found in many weight-loss supplements and is known to interact
negatively with certain prescription drugs. How does the presence of naringin effect the
marketing strategies of releasing new drugs and supplements?”
JH: “The process occurs through the FDA. When you get a number of problems on a product
happening, the FDA steps in and has the power to pull the product from the shelves or ban the
product.”
NS: “Is it common for dietary supplements, particularly weight-loss supplements, to be
inadequately labeled (i.e. leaving out certain ingredients)?”
JH: N/A
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Appendix B
Interview Transcripts: Dr. Susan Swadener
The following interview was conducted to gain expert opinion in the area of dietary needs
based on a questionnaire about the effects of public relations on pharmaceutical companies.
Interviewer: Nicole Schmidt
Respondent: Registered Dietitian (Dr. Susan Swadener)
Date of Interview: 11/23/2011
Interview Transcription:
Nicole Schmidt: “What strategies do public relations officials of pharmaceutical companies use
to gain long-lasting relationships with consumers? What aspects of the public relations area are
dedicated to retaining these relationships?”
Susan Swadener: “[Strategies include] commercials on TV, ads in magazines, websites, and free
samples. I don’t know [the area of public relations that retain these relationships].”
NS: “In what ways are current marketing strategies affecting consumers’ lifestyles (positively or
negatively)? How are strategies adapting to consumers’ changing lifestyles?”
SS: “Perhaps they are more educated, but also they may not need the supplements at all.
[Strategies are adapting to consumers’ changing lifestyles by marketing] that people are too busy
to eat right.”
NS: “Do marketing strategies effectively communicate the risks and adverse side effects that
dietary supplements can have with prescription medication? If so, in what ways? If not, in what
ways could the strategies be improved, and what are the limitations?”
SS: “I am not aware of marketing strategies to communicate risks of drug-supplement
interactions. The strategies could be improved by mentioning medications that are
contraindicated with the supplement.”
NS: “How do pharmaceutical companies educate consumers about the risks of taking dietary
supplements? What measurements are taken to ensure consumers have the right education about
regulation on dietary supplements? What improvements can be taken?”
SS: “I don’t know that companies are educating consumers; I am not aware of them doing that.
The measurement being taken include talking to registered dietitians and looking for information
on the FDA website. The improvements include putting the regulations on the label of the
product.”
NS: “What dietary supplements are known to interact with certain prescription drugs? How
readily are dietary supplements approved by a professional, or suggested by a professional?”
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SS: “Tryptophan and St. John’s Wort are examples of supplements known to interact with
prescription drugs. Supplements are readily suggested if proven effective for the patient.”
NS: “How often are dietary supplements brought to the attention of physicians or a
professionals’ attention?”
SS: “I always ask my clients if they’re taking dietary supplements, as a registered dietitian.”
NS: “Naringin can be found in many weight-loss supplements and is known to interact
negatively with certain prescription drugs. How does the presence of naringin affect the
marketing strategies of releasing new drugs and supplements?”
SS: “Companies need to tell consumers that it [naringin] can decrease the metabolism of certain
drugs and therefore cause toxic levels [to be present in the bloodstream].”
NS: “Is it common for dietary supplements, particularly weight-loss supplements, to be
inadequately labeled (i.e. leaving out certain ingredients)?”
SS: “Sure, many times the supplements contain too little or too high amounts of the active
ingredient.”
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Appendix C
Interview Transcripts: Debby Nicklas
The following interview was conducted to gain expert opinion in the field of public relations
based on a questionnaire about the effects of public relations on pharmaceutical companies.
Interviewer: Nicole Schmidt
Respondent: Executive Director of French Hospital Medical Center (Debby Nicklas)
Date of Interview: 12/2/2011
Interview Transcription:
Nicole Schmidt: “What strategies do public relations officials of pharmaceutical companies use
to gain long-lasting relationships with consumers? What aspects of the public relations area are
dedicated to retaining these relationships?”
Debby Nicklas: “They [companies] must try to generate good PR [public relations] that shows
consumers how they’ve helped. This can be through the use of testimonials or personal
consumer experiences. Companies also want to try to reach out to physicians, and try to generate
good stories of the product. You see a lot of paid advertising as well. Usually, I’m not used to
seeing PR for pharmaceutical drugs, and there can be bad reactions towards some.”
NS: “In what ways are current marketing strategies affecting consumers’ lifestyles (positively or
negatively)? How are strategies adapting to consumers’ changing lifestyles?”
DN: “I think pharmaceutical companies are trying to push how their products can change your
life through advertisements that are happier, more optimistic. Baby boomers are a target
audience, the marketing is geared more towards the positive side of the medication (it replaces
more hardcore procedures of stating what the product simply does). Companies are playing up
the fact that baby boomers want to stay young. The strategies in general, are adapting to the
older population, trying to make them feel better about being older and getting you back to being
active. This depends on the fact that the world is changing, and family members don’t usually
stay near each other, they move away after college or high school. As a result, older members of
the community can’t rely on their families to take them to the hospital or get medication for
them, they can only rely on themselves.
NS: “Do marketing strategies effectively communicate the risks and adverse side effects that
dietary supplements can have with prescription medication? If so, in what ways? If not, in what
ways could the strategies be improved, and what are the limitations?”
DN: “I think they [companies] do. They say potential side effects. I don’t know, as a consumer,
the marketing dietary supplements have, and whether it’s good or bad.”
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NS: “How do pharmaceutical companies educate consumers about the risks of taking dietary
supplements? What measurements are taken to ensure consumers have the right education about
regulation on dietary supplements? What improvements can be taken?”
DN: N/A
NS: “What dietary supplements are known to interact with certain prescription drugs? How
readily are dietary supplements approved by a professional, or suggested by a professional?”
DN: N/A
NS: “How often are dietary supplements brought to the attention of physicians or a
professionals’ attention?”
DN: N/A
NS: “Naringin can be found in many weight-loss supplements and is known to interact
negatively with certain prescription drugs. How does the presence of naringin affect the
marketing strategies of releasing new drugs and supplements?”
DN: N/A
NS: “Is it common for dietary supplements, particularly weight-loss supplements, to be
inadequately labeled (i.e. leaving out certain ingredients)?”
DN: N/A
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